S-1 versus taxanes for HER2-negative metastatic breast cancer

Lancet Oncol. 2016 Jan;17(1):11-2. doi: 10.1016/S1470-2045(15)00470-2. Epub 2015 Nov 24.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology*
  • Female
  • Humans
  • Liver Neoplasms / secondary*
  • Oxonic Acid / therapeutic use*
  • Paclitaxel / therapeutic use*
  • Taxoids / therapeutic use*
  • Tegafur / therapeutic use*

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Phytogenic
  • Taxoids
  • Tegafur
  • Oxonic Acid
  • Paclitaxel